Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1120 | 1037 | 1155 | 1017 | 1160 | 1444 |
Fund Return | 11.97% | 3.74% | 15.47% | 0.56% | 3.01% | 3.74% |
Place in category | 690 | 996 | 772 | 1805 | 1218 | 399 |
% in Category | 23 | 31 | 25 | 72 | 56 | 32 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CM CIC Europe Growth C | 2.04B | -1.68 | -3.85 | 5.66 | ||
Flexigestion Patrimoine | 772.51M | 8.16 | 0.23 | 1.87 | ||
CM CIC Equilibre International D | 666.75M | 11.96 | 0.56 | 3.74 | ||
CM CIC Dynamique International C | 585.1M | 15.96 | 2.41 | 5.28 | ||
Avenir Alizes C | 372.12M | 6.16 | 1.47 | 2.03 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Carmignac Patrimoine A EUR Acc | 6.13B | 6.98 | -0.58 | 1.38 | ||
Carmignac Patrimoine A EUR Ydis | 6.13B | 6.98 | -0.55 | 1.26 | ||
FR0010306142 | 6.13B | 6.48 | -1.05 | 0.89 | ||
QS0009079318 | 1.95B | 5.32 | 1.43 | 3.09 | ||
Aviva Investors Valorisation | 1.49B | 10.39 | 2.48 | 4.56 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Euro Bund Future Dec 24 | - | 16.69 | - | - | |
CM-AM Monéplus IC | FR0010389254 | 6.66 | - | - | |
BlueBay Funds - BlueBay Investment Grade Euro Aggr | LU0549545142 | 5.28 | 176.560 | -0.33% | |
Amundi S&P 500 ESG UCITS Acc EUR | IE000KXCEXR3 | 5.10 | 164.04 | +0.25% | |
Amundi Fds US Eq Fundm Gr I2 USD C | LU1883855675 | 4.87 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review